Literature DB >> 16645106

Outcome of osteochondral autograft transplantation for type-V cystic osteochondral lesions of the talus.

P E Scranton1, C C Frey, K S Feder.   

Abstract

The treatment of osteochondral lesions of the talus has evolved with the development of improved imaging and arthroscopic techniques. However, the outcome of treatment for large cystic type-V lesions is poor, using conventional grafting, debridement or microfracture techniques. This retrospective study examined the outcomes of 50 patients with a cystic talar defect who were treated with arthroscopically harvested, cored osteochondral graft taken from the ipsilateral knee. Of the 50 patients, 45 (90%) had a mean good to excellent score of 80.3 (52 to 90) in the Karlsson-Peterson Ankle Score, at a mean follow-up of 36 months (24 to 83). A malleolar osteotomy for exposure was needed in 26 patients and there were no malleolar mal- or nonunions. One patient had symptoms at the donor site three months after surgery; these resolved after arthroscopic release of scar tissue. This technique is demanding with or without a malleolar osteotomy, but if properly performed has a high likelihood of success.

Entities:  

Mesh:

Year:  2006        PMID: 16645106     DOI: 10.1302/0301-620X.88B5.17306

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  34 in total

Review 1.  Current Concepts: Osteochondritis Dissecans of the Capitellum and the Role of Osteochondral Autograft Transplantation.

Authors:  Jacob M Kirsch; Jared Thomas; Asheesh Bedi; Jeffrey N Lawton
Journal:  Hand (N Y)       Date:  2016-08-24

Review 2.  [Ankle cartilage repair : Therapeutic options, results and technical aspects].

Authors:  S Anders; J Götz; J Grifka; C Baier
Journal:  Orthopade       Date:  2017-11       Impact factor: 1.087

Review 3.  Osteochondral lesions of the talus in the athlete: up to date review.

Authors:  Yoshiharu Shimozono; Youichi Yasui; Andrew W Ross; John G Kennedy
Journal:  Curr Rev Musculoskelet Med       Date:  2017-03

4.  Establishing proof of concept: Platelet-rich plasma and bone marrow aspirate concentrate may improve cartilage repair following surgical treatment for osteochondral lesions of the talus.

Authors:  Niall A Smyth; Christopher D Murawski; Amgad M Haleem; Charles P Hannon; Ian Savage-Elliott; John G Kennedy
Journal:  World J Orthop       Date:  2012-07-18

5.  Good clinical and functional outcomes at mid-term following autologous osteochondral transplantation for osteochondral lesions of the talus.

Authors:  Yoshiharu Shimozono; Eoghan T Hurley; Charles L Myerson; John G Kennedy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-23       Impact factor: 4.342

6.  [Malleolar osteotomy--osteotomy as approach].

Authors:  A Barg; G Pagenstert; A Leumann; V Valderrabano
Journal:  Orthopade       Date:  2013-05       Impact factor: 1.087

7.  Role of arthroscopic microfracture for cystic type osteochondral lesions of the talus with radiographic enhanced MRI support.

Authors:  Hong-Geun Jung; John Alistair V Carag; Jae-Yong Park; Tae-Hoon Kim; Sung-Gyu Moon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-02-12       Impact factor: 4.342

8.  Autologous osteochondral transplantation for osteochondral lesions of the talus in an athletic population.

Authors:  Ethan J Fraser; Mark C Harris; Marcelo P Prado; John G Kennedy
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-05-12       Impact factor: 4.342

9.  Repair of articular cartilage defects in the knee with autologous iliac crest cartilage in a rabbit model.

Authors:  Lizhong Jing; Jiying Zhang; Huijie Leng; Qinwei Guo; Yuelin Hu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-27       Impact factor: 4.342

Review 10.  Treatment of osteochondral lesions of the talus: a systematic review.

Authors:  Maartje Zengerink; Peter A A Struijs; Johannes L Tol; Cornelis Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-10-27       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.